To explore the regulatory role of Flot-1 sumoylation in prostate cancer, we examined mitogen-response sumoylation of Flot-1, and its relation to the metastatic potential, comparing PC3 and LNCaP cells with high and low metastatic potential [27], respectively. The gene discussed is FLOT1; the disease is prostate carcinoma.